Six-Year Results from RELEVANCE: Lenalidomide Plus Rituximab (R2) Versus Rituximab-Chemotherapy Followed by Rituximab Maintenance in Untreated Advanced Follicular Lymphoma

1. Morschhauser, F.
2. Nastoupil, L.
3. Feugier, P.
4. De Colella, J.-M.S.
5. Tilly, H.
6. Palomba, M.L.
7. Bachy, E.
8. Fruchart, C.
9. Libby, E.N.
10. Casasnovas, R.-O.
11. Flinn, I.W.
12. Haioun, C.
13. Maisonneuve, H.
14. Ysebaert, L.
15. Bartlett, N.L.
16. Bouabdallah, K.
17. Brice, P.
18. Ribrag, V.
19. Le Gouill, S.
20. Daguindau, N.
21. Guidez, S.
22. Pica, G.M.
23. García-Sancho, A.M.
24. López-Guillermo, A.
25. Larouche, J.-F.
26. Ando, K.
27. Gomes Da Silva, M.
28. André, M.
29. Kalung, W.
30. Sehn, L.H.
31. Izutsu, K.
32. Cartron, G.
33. Gkasiamis, A.
34. Crowe, R.
35. Xerri, L.
36. Fowler, N.H.
37. Salles, G.
38. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1200/JCO.22.00843 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus